Free Trial

Equifax (EFX) Stock Forecast & Price Target

Equifax logo
$237.24 +0.57 (+0.24%)
Closing price 10/6/2025 03:59 PM Eastern
Extended Trading
$237.26 +0.01 (+0.01%)
As of 09:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Equifax - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
8
Buy
13

Based on 21 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 21 analysts, 8 have given a hold rating, 12 have given a buy rating, and 1 has given a strong buy rating for EFX.

Consensus Price Target

$282.47
19.06% Upside
According to the 21 analysts' twelve-month price targets for Equifax, the average price target is $282.47. The highest price target for EFX is $305.00, while the lowest price target for EFX is $240.00. The average price target represents a forecasted upside of 19.06% from the current price of $237.24.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EFX Analyst Ratings Over Time

TypeCurrent Forecast
10/7/24 to 10/7/25
1 Month Ago
9/7/24 to 9/7/25
3 Months Ago
7/9/24 to 7/9/25
1 Year Ago
10/8/23 to 10/7/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
16 Buy rating(s)
Hold
8 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$282.47$283.53$295.19$306.95
Forecasted Upside19.06% Upside13.50% Upside11.08% Upside8.78% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Equifax Stock vs. The Competition

TypeEquifaxBusiness Services CompaniesS&P 500
Consensus Rating Score
2.67
2.08
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside19.06% Upside95.74% Upside170.00% Upside
News Sentiment Rating
Positive News

See Recent EFX News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/3/2025Morgan Stanley
3 of 5 stars
 Reiterated RatingOverweight
10/3/2025Bank of America
4 of 5 stars
Heather Balsky
Not Rated
Lower TargetNeutral$285.00 ➝ $250.00+5.94%
10/1/2025Seaport Res Ptn
4 of 5 stars
 UpgradeHold
9/27/2025Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingHold (C+)
9/15/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$287.00 ➝ $297.00+15.81%
7/23/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$294.00 ➝ $290.00+17.77%
7/23/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetMarket Perform$280.00 ➝ $260.00+5.70%
7/23/2025Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$296.00 ➝ $279.00+13.57%
7/23/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$277.00 ➝ $272.00+11.68%
7/23/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$310.00 ➝ $300.00+23.53%
7/23/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$310.00 ➝ $289.00+20.86%
7/23/2025Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetEqual Weight$260.00 ➝ $240.00+0.37%
6/20/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$295.00+16.37%
6/18/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$277.00 ➝ $295.00+15.31%
6/18/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$300.00+17.51%
3/14/2025BNP Paribas
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformNeutral$265.00+11.75%
2/18/2025Gordon Haskett
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
2/11/2025Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyHold
2/7/2025William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingOutperform
1/15/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$340.00 ➝ $300.00+13.77%
12/12/2024Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformPeer Perform
8/20/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetNeutral$277.00 ➝ $307.00+4.23%
2/13/2024Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeIn-LineOutperform$210.00 ➝ $310.00+21.21%
2/9/2024Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$270.00 ➝ $285.00+14.38%
1/11/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyNeutral$272.00+11.10%
12/8/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeHoldBuy$218.00 ➝ $267.00+19.05%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:27 AM ET.


Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 3, 2025. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Equifax Inc.:

  • The current stock price is around $264, reflecting a recent increase, which may indicate positive market sentiment towards the company.
  • Equifax Inc. reported earnings per share of $2.00, surpassing analysts' expectations, which suggests strong financial performance and potential for future growth.
  • The company has shown a revenue increase of 7.4% compared to the same quarter last year, indicating a solid growth trajectory.
  • Equifax Inc. has a market capitalization of approximately $32.73 billion, which positions it as a significant player in the credit services industry, potentially offering stability to investors.
  • The firm recently announced a quarterly dividend of $0.50, providing a return to shareholders and demonstrating a commitment to returning value to investors.

Equifax
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Equifax Inc. for these reasons:

  • The company's high price-to-earnings (P/E) ratio of 51.74 may suggest that the stock is overvalued compared to its earnings, which could deter value-focused investors.
  • Equifax Inc. has a relatively low current ratio of 0.77, indicating potential liquidity issues, which could affect its ability to meet short-term obligations.
  • Insider selling activity, including a significant sale by the CEO, may raise concerns about the company's future prospects and management confidence.
  • The stock has a beta of 1.68, suggesting higher volatility compared to the market, which could pose risks for more conservative investors.
  • With institutional investors holding 96.20% of the company's stock, individual investors may find it challenging to influence company decisions or benefit from significant price movements.

EFX Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $282.47, with a high forecast of $305.00 and a low forecast of $240.00.

21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last year. There are currently 8 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EFX shares.

According to analysts, Equifax's stock has a predicted upside of 19.06% based on their 12-month stock forecasts.

Over the previous 90 days, Equifax's stock had 1 upgrade by analysts.

Analysts like Equifax more than other "business services" companies. The consensus rating for Equifax is Moderate Buy while the average consensus rating for "business services" companies is Hold. Learn more on how EFX compares to other companies.


This page (NYSE:EFX) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners